Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastasis and angiogenesis.

Matthias Kirsch1, Gabriele Schackert, Peter McL Black

  • 1Klinik und Poliklinik für Neurochirurgie, Technische Universität Dresden, Germany.

Cancer Treatment and Research
|March 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statins May Not Reduce Reoperation Rates in Chronic Subdural Hematoma, Regardless of the Use of Antithrombotic Medication.

Journal of neurological surgery. Part A, Central European neurosurgery·2026
Same author

Correction: Jugel et al. Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers. <i>Cancers</i> 2022, <i>14</i>, 1925.

Cancers·2026
Same author

Molecular landscape and clinical correlates of olfactory groove meningiomas: a multi-institutional study.

Journal of neurosurgery·2025
Same author

Post-traumatic hydrocephalus after decompressive craniectomy: a multidimensional analysis of clinical, radiological, and surgical risk factors.

Neurosurgical review·2025
Same author

Managing hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysis.

International journal of cancer·2025
Same author

Long-term outcomes of peripheral nerve field stimulation in patients with refractory trigeminal neuralgia: a cohort study.

Journal of neurosurgery·2025
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Endogenous angiogenesis inhibitors can maintain dormant metastases, preventing their growth. Therapeutic targeting of these inhibitors shows promise for treating brain metastases, including gliomas.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment

Background:

  • Angiogenesis is crucial for metastasis establishment and growth.
  • Tumor-secreted factors, including angiogenesis inhibitors, can induce a dormant state in metastases.
  • This dormancy is characterized by inhibited neovascularization, normal proliferation, and increased apoptosis.

Purpose of the Study:

  • To explore the role of endogenous angiogenesis inhibitors in maintaining metastatic dormancy.
  • To investigate the potential therapeutic applications of these inhibitors, particularly for cerebral metastases and gliomas.

Main Methods:

  • Review of experimental data on angiogenesis inhibitors and metastasis.
  • Analysis of mechanisms underlying metastatic dormancy in various tumors.

Related Experiment Videos

  • Examination of therapeutic trials involving endogenous angiogenesis inhibitors.

    • Main Results:

    • Endogenous inhibitors of angiogenesis maintain dormant metastases by preventing neovascularization.
    • Removal of these inhibitors can lead to the growth of dormant metastases.
    • Glioma cell dormancy in the brain may also be regulated by endogenous inhibitory mechanisms.

    Conclusions:

    • Endogenous angiogenesis inhibitors play a critical role in controlling metastatic growth.
    • Targeting these inhibitors offers a potential therapeutic strategy for managing metastases, especially in the brain.
    • Further research into these mechanisms could lead to novel treatments for malignant brain tumors.